In the early days of the COVID-19 pandemic, doctors in Wuhan noticed something surprising. Many of the elderly patients who survived the virus were poor: not exactly the demographic you would expect to fare well in a health crisis. A review of the survivors’ medical records revealed that a significant number suffered from chronic heartburn
Study shows potential of heartburn drug for COVID-19 According to an observational study, which was conducted at Irving, Medical Center of Columbia University (USA), could help a common drug for heartburn by the Coronavirus SARS-CoV-2-induced disease COVID-19. In a new study has shown that COVID-19-patients and in -patients in the Famotidine, a common drug for
Tesco, Sainsbury’s and ASDA recall own-brand versions of the heartburn and indigestion drug Zantac over fears they are contaminated with a cancer-causing chemical The supermarket products were among 13 new additions to an ongoing recall Products in the UK and US have been taken off shelves due to contamination Ranitidine drugs are thought to have
Unintended weight loss This is often the first noticeable symptom of cancer of either the oesophagus, pancreas, stomach and lungs. According to cancer.net around 40 per cent of people say they had unexplained weight loss when they were first diagnosed with cancer. Change in bladder or bowel function Changes in bowel habit are counted as
The fact that GERD Awareness Week occurs annually during Thanksgiving should be the first clue that it’s digestive related. Heartburn is the most common symptom of GERD, or Gastroesophageal Reflux Disease. This treatable disease affects up to 1 in 5 people, according to the International Foundation for Functional Gastrointestinal Disorders (IFFGD). What is it? Simply
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok